These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20605952)

  • 1. Membrane transport and intracellular sequestration of novel thiosemicarbazone chelators for the treatment of cancer.
    Merlot AM; Pantarat N; Lovejoy DB; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2010 Oct; 78(4):675-84. PubMed ID: 20605952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake of the antitumor agent Dp44mT occurs via a carrier/receptor-mediated mechanism.
    Merlot AM; Pantarat N; Menezes SV; Sahni S; Richardson DR; Kalinowski DS
    Mol Pharmacol; 2013 Dec; 84(6):911-24. PubMed ID: 24085840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
    Potůčková E; Roh J; Macháček M; Sahni S; Stariat J; Šesták V; Jansová H; Hašková P; Jirkovská A; Vávrová K; Kovaříková P; Kalinowski DS; Richardson DR; Šimůnek T
    PLoS One; 2015; 10(10):e0139929. PubMed ID: 26460540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
    Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
    J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
    Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
    Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
    Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy.
    Serda M; Kalinowski DS; Mrozek-Wilczkiewicz A; Musiol R; Szurko A; Ratuszna A; Pantarat N; Kovacevic Z; Merlot AM; Richardson DR; Polanski J
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5527-31. PubMed ID: 22858101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
    Richardson DR
    Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9.
    Debebe Z; Ammosova T; Breuer D; Lovejoy DB; Kalinowski DS; Kumar K; Jerebtsova M; Ray P; Kashanchi F; Gordeuk VR; Richardson DR; Nekhai S
    Mol Pharmacol; 2011 Jan; 79(1):185-96. PubMed ID: 20956357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells.
    Merlot AM; Sahni S; Lane DJ; Fordham AM; Pantarat N; Hibbs DE; Richardson V; Doddareddy MR; Ong JA; Huang ML; Richardson DR; Kalinowski DS
    Oncotarget; 2015 Apr; 6(12):10374-98. PubMed ID: 25848850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity.
    Yu Y; Suryo Rahmanto Y; Hawkins CL; Richardson DR
    Mol Pharmacol; 2011 Jun; 79(6):921-31. PubMed ID: 21389104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell permeable iron chelators as potential cancer chemotherapeutic agents.
    Pahl PM; Horwitz LD
    Cancer Invest; 2005; 23(8):683-91. PubMed ID: 16377587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity.
    Basha MT; Chartres JD; Pantarat N; Ali MA; Mirza AH; Kalinowski DS; Richardson DR; Bernhardt PV
    Dalton Trans; 2012 Jun; 41(21):6536-48. PubMed ID: 22362375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS identification of the principal in vitro and in vivo phase I metabolites of the novel thiosemicarbazone anti-cancer drug, Bp4eT.
    Stariat J; Sesták V; Vávrová K; Nobilis M; Kollárová Z; Klimeš J; Kalinowski DS; Richardson DR; Kovaříková P
    Anal Bioanal Chem; 2012 Apr; 403(1):309-21. PubMed ID: 22349326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
    Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
    Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayers.
    Debebe Z; Nekhai S; Ashenafi M; Lovejoy DB; Kalinowski DS; Gordeuk VR; Byrnes WM; Richardson DR; Karla PK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 906():25-32. PubMed ID: 22954966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.
    Yu Y; Wong J; Lovejoy DB; Kalinowski DS; Richardson DR
    Clin Cancer Res; 2006 Dec; 12(23):6876-83. PubMed ID: 17145804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.